Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule-and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response

Clinical Chemistry

Volumn 61, Issue 1, 2015, Pages 259-266

  Satelli, Arun ^a   Brownlee, Zachary ^a   Mitra, Abhisek ^a   Meng, Qing H ^b   Li, Shulin ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE VIMENTIN; EPITHELIAL CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; VIMENTIN; CELL ADHESION MOLECULE; TUMOR ANTIGEN; TUMOR MARKER; TUMOR-ASSOCIATED ANTIGEN GA733;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST METASTASIS; CANCER PATIENT; CELL COUNT; CIRCULATING TUMOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PILOT STUDY; PREDICTIVE VALUE; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SARCOMA; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; BLOOD; BREAST NEOPLASMS; CELL MEMBRANE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; METASTASIS; PATHOLOGY; TREATMENT OUTCOME; TUMOR EMBOLISM;

COCKSFOOT STREAK VIRUS;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL COUNT; CELL MEMBRANE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84920509099     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.228122     Document Type: Article

References (16)

1. Alix-Panabieres C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013;59:110-8.
2. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904.
3. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
4. Urtishak S, Alpaugh RK, Weiner LM, Swaby RF. Clinical utility of circulating tumor cells: a role for monitoring response to therapy and drug development. Biomark Med 2008;2:137-45.
5. Riethdorf S, Muller V, Zhang L, Rau T, Loibl S, Komor M, et al. Detection and her2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant geparquattro trial. Clin Cancer Res 2010;16:2634-45.
6. Lianidou ES. Circulating tumor cell isolation: a marathon race worth running. Clin Chem 2014;60:287-9.
7. Lowes LE, Allan AL. Recent advances in the molecular characterization of circulating tumor cells. Cancers 2014;6:595-624.
8. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13:920-8.
9. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normallike breast tumor cells. J Natl Cancer Inst 2009;101: 61-6.
10. Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, et al. Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res 2014; 74:1645-50.
11. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011;68:3033-46.
12. Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 2011;105: 847-53.
13. Pavlidis P, Noble WS. Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003;19:295-6.
14. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4.
15. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, et al. Nuclear signalling by tumour-associated antigen epcam. Nat Cell Biol 2009;11:162-71.
16. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68:989-97.